# Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

> **NCT04419779** · NA · SUSPENDED · sponsor: **Fractyl Health Inc.** · enrollment: 320 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Duodenal Mucosal Resurfacing (DMR)
- **DEVICE:** Duodenal Mucosal Resurfacing (Sham)

## Key facts

- **NCT ID:** NCT04419779
- **Lead sponsor:** Fractyl Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-03-08
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 320 (ESTIMATED)
- **Why stopped:** Enrollment pause
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04419779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04419779, "Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04419779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*